$50 Million Dosage And Capsule Plant For Turkey

---

Researched by Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas). A $50 million pharmaceutical plant in Gebze, Turkey, near Istanbul, is due to start production early in 2003. The new Roche (NYSE:RIHBY; LONDON SEAQ:ROG) (Basel, Switzerland) Mustahzarlari facility will make solid dosage forms, including packaging of the finished products. Foster Wheeler Italiana S.p.A., a subsidiary of Foster Wheeler Corporation (NYSE:FWC) (Clinton, New Jersey) is fulfilling the engineering, procurement, and construction management contract. The project includes the design and construction of quality control laboratories, warehousing, and offices, and the required infrastructure.

The plant will make both hard gelatine capsules and soft elastic capsules. Hard gelatine capsules are used to hold dry powders and can be supplied and filled extemporaneously, whereas soft gelatine capsules cannot be filled extemporaneously and must be sealed after filling.